The uptake and intracellular metabolism of 4-(1-pyrene)butanoic acid (P4), 10-(1-pyrene)decanoic acid (PlO) and 12-(1-pyrene)dodecanoic acid (P12) were investigated in cultured lymphoid cell lines from normal individuals and from a patient with multisystemic lipid storage myopathy (MLSM). The cellular uptake was shown to be dependent on the fatty-acid chain length, but no significant difference in the uptake of pyrene fatty acids was observed between MLSM and control lymphoid cells. After incubation for I h the distribution of fluorescent fatty acids taken up by the lymphoid cell lines also differed with the chain length, most of the fluorescence being associated with phospholipid and triacylglycerols. In contrast with PlO and P12, P4 was not incorporated into neutral lipids. When the cells were incubated for 24 h with the pyrene fatty acids, the amount of fluorescent lipids synthesized by the cells was proportional to the fatty acid concentration in the culture medium. After a 24 h incubation in the presence of PIO or P12, at any concentration, the fluorescent triacylglycerol content of MLSM cells was 2-5-fold higher than that of control cells. Concentrations of pyrene fatty acids higher than 40 ,M seemed to be more toxic for mutant cells than for control cells. This cytotoxicity was dependent on the fluorescent-fatty-acid chain length (P12 > PlO > P4). Pulse-chase experiments permitted one to demonstrate the defect in the degradation of endogenously biosynthesized triacylglycerols in MLSM cells (residual activity was around 10-25 % of controls on the basis of half-lives and initial rates of PlO-or P12-labelled-triacylglycerol catabolism); MLSM lymphoid cells exhibited a mild phenotypic expression of the lipid storage (less severe than that observed in fibroblasts). P4 was not utilized in the synthesis of triacylglycerols, and thus did not accumulate in MLSM cells: this suggests that natural short-chain fatty acids might induce a lesser lipid storage in this disease.
INTRODUCTION
Multisystemic lipid storage myopathy (MLSM) is a rare inborn error of metabolism generally characterized by the association of muscular weakness, ichthyosis, multisystemic triacylglycerol storage, Jordans' anomaly (fat vacuoles in leucocytes) without deficiency in carnitine or carnitine acyltraftsferase (Jordans, 1953; Chanarin et al., 1975; Angelini et al., 1978; Angelini, 1984) . When grown in a medium supplemented with 100% fetal calf serum cultured skin fibroblasts from MLSM patients contained numerous cytoplasmic lipid vacuoles and accumulated 8-10 times more triacylglycerols than controls (Chanarin et al., 1975; Radom et al., 1988a) . When radioactive fatty acids were used, MLSM cultured skin fibroblasts stored more radiolabelled triacylglycerols than did controls (Radom et al., 1987a; Di Donato et al., 1988) .
Cultured human skin fibroblasts have been used as cellular model of MLSM (Chanarin et al., 1975; Radom et al., 1987a Radom et al., ,b, 1988a Di Donato et al., 1988) , but this experimental model has several disadvantages: limited lifespan, aging in culture and modification of enzyme activities during senescence (Sun et al., 1975) . In contrast, Epstein-Barr-virus-transformed lymphoid cell lines (LCL) have several advantages over fibroblasts: unlimited lifespan, short doubling time and growth in suspension, permitting the production of large quantities of cellular material (Pope et al., 1968; Glade & Beratis, 1976; Povey, 1976; Salvayre et al., 1983) . In a previous paper the validity of this new experimental model was demonstrated: LCL from a MLSM patient showed a marked accumulation of triacylglycerols (Radom et al., 1988b) .
Elsewhere, the use of pyrene derivatives of fatty acids and phospholipids to measure lateral diffusion, lipid exchange between different vesicles, translocation, phase-separation phenomena and lipid-protein interaction has been widely reported (Galla & Hartman, 1980) . Pyrene lipids have been used as substrates for lipolytic enzymes, e.g. sphingomyelinase and lipases Levade et al., 1986; Salvayre et al., 1986; Klar et al., 1988) . Previous studies have demonstrated that 12-(1-pyrene)dodecanoic acid (P12) was taken up by cultured cells and incorporated in the cellular neutral lipids and phospholipids (Morand et al., 1982 (Morand et al., , 1984 Gatt et al., 1988) . Measurement of the incorporation and of the intracellular metabolism of this intensely fluorescent fatty acid have been used to differentiate normal and lipidotic cells (Levade & Gatt, 1987; Radom et al., 1987b) .
In effect of high pyrene-fatty-acid concentrations on the cell viability.
MATERIALS AND METHODS Chemicals
4-(1-Pyrene)butanoic acid (P4), 10-(l-pyrene)decanoic acid (PlO), and P12 were purchased from Molecular Probes (Eugene, OR, U.S.A.), bovine fatty-acid-free albumin from Sigma (St. Louis, MO, U.S.A.), silica-gel G thin layers from Merck (Darmstadt, Germany), RPMI 1640, fetal-calf serum, glutamine, streptomycin and penicillin from Seromed (Strasbourg, France), Ultroser HY from IBF (Villeneuve-la-Garenne, France), phospholipase A2 from pig pancreas (Boehringer-Mannheim, Germany) and the other reagents and organic solvents from Merck or Prolabo (Paris, France).
Cell culture LCL were established by Epstein-Barr-virus transformation (B95/8 strain) of blood B-lymphocytes (Pope et al., 1968; Salvayre et al., 1981) from normal individuals (lines Be, C49 and Lau) and from a woman affected with MLSM (line Bo). LCL were grown at 37°C in C02/air (1:19) in RPMI 1640 medium supplemented with penicillin (100 units/ml), streptomycin (100 ,g/ml), glutamine (2 mM) and 10% inactivated fetal-calf serum. Cell viability was assessed by the Trypan Blue dyeexclusion test and by [3H]thymidine incorporation.
Incubation of LCL with fluorescent fatty acids LCL were usually grown in RPMI 1640 containing 2 % Ultroser HY (a serum substitute) for 2 days before studies were initiated. The pyrene fatty acid was solubilized in dimethyl sulphoxide (final concn. 0.05 %), added at the indicated concentration to the incubation medium (RPMI 1640 containing 2 % Ultroser HY) and preincubated at 37°C for 30 min. At the beginning of the pulse, the medium containing pyrene fatty acid was mixed with the cell suspension in tissue-culture flasks (final vol. 3 ml/flask). The final concentration of pyrene fatty acid in the medium was 33 nmol/ml and the initial concentration of cells was 1 x 10fi.ml. Under these conditions, pyrene fatty acid and dimethyl sulphoxide had no adverse effect on cell viability (as determined by the Trypan Blue-dye-exclusion test). At the end of the incubation period with the fluorescent fatty acid derivative, lymphoid cells were sedimented by centrifugation, washed once with phosphate-buffered saline (8 mM-sodium phosphate/0. 14 MNaCl, pH 7.4) supplemented with 10 gM-BSA (essentially fattyacid-free) and twice with the phosphate-buffered saline. For chase experiments, after incubation for 24 h with the fluorescent fatty acid, the cells were pelleted by centrifugation (time 0 of the chase) and chased for the indicated periods in a medium containing 10 % (v/v) fetal-calf serum.
Lipid extraction and analysis
The cell pellets were suspended in 0.8 ml of distilled water and sonicated (2 cycles of 15 s; Soniprep 150 sonicator). The lipids of the cell suspensions were extracted with chloroform/methanol (2:1, v/v) (Folch et al., 1957) . The fluorescent lipid classes were separated by on silica-gel G plates, using the following solvent systems: light petroleum (b.p. 35-60 C)/diethyl ether/acetic acid (80:20:1, by vol.) , for the separation of the neutral lipids and chloroform/methanol/water (50:21:3, by vol.) for the separation of the phospholipids; then lipids were scraped off and their relative fluorescence intensity was determined as previously described (Radom et al., 1987b) .
In order to determine the position of the pyrene fatty acid in the phospholipid molecules, the total phospholipid fractions were hydrolysed with phospholipase A2 (Okuyama & Nojima, 1965) . The lysophospholipids obtained were analysed for their pyrene fatty acid content as described above.
The critical micellar concentration of pyrene fatty acids in phosphate-buffered saline was evaluated as reported by Galla et al. (1979) (Schwartz, 1981) .
RESULTS

Kinetics of uptake and incorporation of fluorescent fatty acids
The time course of the fatty acid uptake by LCL was investigated by using three fluorescent fatty acids at 37°C in the absence of fetal-calf serum (Fig. 1) . The rate of incorporation of fatty acid in LCL was related to the acyl chain length: the initial rates evaluated during the first minutes of the pulse (under the conditions used, the linearity of the uptake did not hold beyond 1-2 min) were 0.04 and 0.04 nmol/min per mg for P4, 1.67 and 1.84 nmol/min per mg for PIO, and 3.75 and 3.93 nmol/min per mg for P12 in MLSM and control cells respectively, these results indicating no significant difference between control and MLSM cells. After a 1 h pulse, the amount of fluorescent fatty acid taken up by the cells was about 1, 10 and 20 nmol/mg of cell protein for P4, PlO and P12 respectively.
The distribution of fluorescent fatty acids in the various lipid classes of lymphoid cells also differed with the fatty acid chain length (Fig. 2) . Most of the PlO and P12 was incorporated into phospholipids and triacylglycerols, whereas P4 was only incorporated into phospholipids. At any time during the pulse, the fluorescent phospholipid levels were not significantly different between control and MLSM cells. The incorporation of fluorescent fatty acids into triacylglycerols was obviously dependent on the chain length: PlO and P12 were incorporated in triacylglycerols, whereas P4 was not. When evaluated in the first minutes of the pulse, the initial rates of fluorescent triacylglycerol biosynthesis were 0.12 and 0.11 nmol/min per mg of cell protein with PlO, and 0.75 and 0.70 nmol/min per mg with P12, in control and MLSM cells respectively; after a 1 h pulse, the values were 3.2 and 3.1 with PlO and 8.2 and 7.5 nmol/mg in MLSM and control cells respectively.
Effect of the concentration of pyrene fatty acids on their uptake and metabolism
The incorporation of pyrene fatty acids into lymphoid cells after 24 h incubation was dependent on their chain length and concentration in the culture medium (Fig. 3) . The amounts of PlO and P12 incorporated into MLSM cells were 1.2-1.5-fold greater than in controls, whereas with P4 no difference was observed between MLSM and normal cells (Fig. 3a) .
The analysis of fluorescent phospholipids revealed several differences in the metabolic utilization of pyrene fatty acids.
When PlO (33 /tM) was used, the fluorescence in phospholipids was distributed as follows: phosphatidylcholine, 55 + 4%; phosphatidylethanolamine, 40 + 2%; phosphatidylinositol and/ or phosphatidylserine, 5+1%. Similar results were obtained with P12. When P4 was used, phosphatidylcholine represented more than 73 % of the fluorescent lipids (results not shown). To determine the location of the pyrene fatty acids on the glycerol backbone of the phospholipids, phospholipase A2 was allowed to react with the total phospholipid extracts until there was complete hydrolysis of the phospholipids; the quantitative analysis of the products showed that P0 and P12 were mainly incorporated into the sn-1 position, whereas P4 was only incorporated into the sn-2 position (Table 1) . ), during short (a) and longer (b) pulse (c shows uptake of fatty acids as a function of fatty acid carbon-atom number) Pyrene fatty acid (33 nmol/ml) was dispersed in warmed culture medium (RPMI 1640 containing 2 % Ultroser) and added to the cells. Incubation was stopped after various times by cooling the Petri dishes on ice (for time 0 the cells were immediately put on ice after the addition of the fluorescent fatty acids). The cells were washed once with phosphate-buffered saline containing 10 ,umol of BSA (fatty-acid-free)/l and twice with phosphate-buffered saline without albumin. Fluorescent cellular lipids were extracted and quantified as described in the Materials and methods section. Each point represents the mean for four separate experiments. Fig. l(a) (Figs. 3b and 3c) . Fig. 3 . Effect of the concentration of pyrene fatty acid in the culture medium on its incorporation into lipids of MLSM (----) and normal( ) LCL LCL were incubated at 37°C for 24 h in RPMI 1640 supplemented with 20% Ultroser and various pyrene-fatty-acid concentrations.
The cells were washed, the lipids were extracted, separated, and their fluorescence intensity was determined as described in the Materials and methods section. 
Degradation of cellular fluorescent lipids
The time course of the catabolism of the endogenously biosynthesized fluorescent lipids was monitored by incubating the cells for 15-20 days in full medium (Fig. 4) . When cells pulsed with P4 were chased for 19 days, the fluorescence decreased rapidly, similarly to control and MLSM cell lines (Fig. 4a) . For cells pulsed with PIO, the level of PlO lipids decreased with time in both cell types, but more slowly in MLSM cells (Fig. 4b) . At time 0 of the chase the content of PlO triacylglycerols was 4 times higher in MLSM cells than in controls. During the chase period PlO triacylglycerols decreased, but a clear difference in the apparent half-lives of PIO triacylglycerols between the two cell lines was observed (11 +2 and 1 + 0.3 days for MLSM and control cells respectively). The ratio of triacylglycerols to phospholipids increased with time in MLSM cells, whereas it decreased in controls (Fig. 4b2 inset) . Very similar results were obtained when P12 was used, the half-lives of P12 triacylglycerols being 12 + 3 days and 2 + 0.5 days in MLSM and control cells respectively. Short chase experiments allowed one to calculate the initial rates of triacylglycerol degradation: for Pl0, ) LCL The cells were incubated at 37°C for 24 h (pulse period) in RPMI 1640 supplemented with 2% Ultroser HY and pyrene fatty acid (33 nmol/ml). Then the medium was removed and replaced by fresh medium supplemented with 10 % fetal-calf serum, and cells were incubated at 37°C (chase period). At the indicated times, cells were washed, lipids were extracted, separated, and fluorimetrically quantified as described in the Materials and methods section. During the chase, the decrease in the cell-associated fluorescence was accompanied by an increase in the fluorescence in the culture medium (Table 3 ). The fluorescence recovered in the culture medium during the chase experiments was due to non-esterified fluorescent fatty acid. When MLSM and control cells were pulsed with P4, almost all the intracellular fluorescence was recovered in the culture medium after 10 days' chase. In contrast, for cells pulsed with PlO and P12, the release of the fluorescence into the culture medium was slower in MLSM than in normal cells. Under the experimental conditions reported in Fig. 4 , the lipids from the culture medium were extracted and analysed as described in the Materials and methods section. (Morand et al., 1984; Levade & Gatt, 1987; Radom et al., 1987b) . In the present paper the comparative study of the uptake of three pyrene fatty acids with various chain lengths and of their metabolic utilization by LCL from MLSM and controls allows one to demonstrate that: (i) the uptake of fluorescent fatty acids by lymphoblasts, their subsequent incorporation into phospholipids and triacylglycerols and their cytotoxic effect 'are strongly dependent on their chain length; (ii) there is a defect in the catabolism of the endogenously biosynthesized triacylglycerols in the lymphoid cells from MLSM.
When administered to the cells at relatively low concentration (33 /tM), without any adverse effect on the cell viability, the pyrene fatty acids were taken up by the lymphoid cells with a clear selectivity for the longer-chain fatty acid derivatives. The difference of uptake could be related to the value of their critical micellar concentration (1300 /tM, 80 ,M and 1 /tM, for P4, Pl0
and P12 respectively) and to the relative solubility of the pyrene derivatives in the membrane lipid phase and in the aqueous phase. Our data well agree with those reported by Morand et al. (1982) on the preferential uptake of P12 compared with PlO in HL60 cells, and with the results obtained using natural fatty acids with various chain lengths in adult rat heart myocytes (De Grella & Light, 1980a,b) . In agreement with Pownall & Smith (1989), the short-acyl-chain derivative, P4, was less efficiently taken up and utilized by cells than the longer-chain pyrene fatty acids, PlO and P12. The fact that the metabolic utilization of fluorescent fatty acids is dependent-on the acyl chain length could be explained in at least three possible ways: (i) the amount of non-esterified fatty acid associated with the cells (increasing from P4 to P12), (ii) the rate of acyl-CoA formation, which is also acyl-chain-lengthdependent (Bremer & Norum, 1982) , and (iii) the acyl-chainspecificity of the acyltransferases (Coleman & Bell, 1976 (Coleman & Bell, 1976) , but utilizes only acyl-CoA with an acyl chain longer than 12 carbon atoms (Hosaka et al., 1977); (ii) the low concentration of intracellular P4, since triacylglycerol synthesis is stimulated by a high intracellular influx of fatty acids, as discussed above (Schneeberger et al., 1971) . The metabolic defect of MLSM cells was investigated in shorttime-pulse and pulse-chase experiments. The short pulse permitted evaluation of initial rates of fatty acid uptake. Our values are consistent with those found by Morand et al. (1982) for HL60 cells and by Samuel et al. (1976) for cardiac cells. These short-time experiments investigated the first phase of PIO and P12 uptake, which is thought to represent the association with, and the insertion of the fluorescent fatty acid into, the cell plasma membrane (Nahas et al., 1987 (Radom et al., 1987a,b; Di Donato et al., 1988) . However, the degradation of triacylglycerols was not as completely blocked in lymphoid cells as in fibroblasts, suggesting some residual catabolic activity in the lymphoblasts from the MLSM patient (about 20-25 % of controls on the basis of the initial catabolic rates). This mild phenotypic expression of the disease in lymphoid cells is in good agreement with the lack of triacylglycerol storage in circulating blood lymphocytes (Chanarin et al., 1975) .
The block of endogenously biosynthesized triacylglycerols seems to be the primary metabolic defect of MLSM, but the molecular basis of this catabolic block is still unknown, since assays in vitro did not show any deficiency in lipase activities of cultured fibroblasts (Di Donato et al., 1988) or lymphoid cells (Radom et al., 1988b (Radom et al., , 1989 . Several hypotheses can be proposed, including the deficiency of a lipase activator molecule or the inaccessibility of triacylglycerols to the lipase.
The cytotoxicity induced by high concentrations of pyrene fatty acids increased with the chain length of the pyrene fatty acids, with the total fluorescence associated with the cells and/or with the cellular content of non-fluorescent triacylglycerols. The mechanism of the cytotoxicity of fluorescent fatty acids could involve a photochemical effect in cells containing high levels of pyrene lipids . The significantly higher sensitivity of MLSM cells (to the toxic effect of fluorescent fatty acids) is probably related to their higher lipid content. The cytotoxicity could result from either a direct effect of fluorescent lipids or an indirect effect of cytoplasmic vacuoles filled with natural triacylglycerols, which could amplify the emission intensity of fluorescent lipids, as has demonstrated in Wolman cells .
Epstein-Barr-virus-transformed LCL seem to be a valid experimental model system of MLSM that exhibits a mild phenotypic expression of the lipid storage [less severe than that observed in fibroblasts by Radom et al. (1987b) ]. Thus those LCL may constitute a good model system complementing that with cultured fibroblasts, with which to gain an insight into normal intracellular neutral lipid metabolism and the pathogeny of MLSM. A comparison of the metabolic utilization of pyrene fatty acids with different acyl chain lengths showed that P4 was not utilized in the synthesis of triacylglycerols and thus did not accumulate in MLSM cells. These data suggest that natural short-chain fatty acids could induce diminished triacylglycerol storage in this disease, in spite of their possible chain-length elongation.
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